Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET
Company Participants
Matthew Kreps - Darrow Associates, IR
Heather Mason - Interim CEO
Ajay Patel - CFO
Paul Schwichtenberg - Chief Commercial Officer
Conference Call Participants
Jim Sidoti - Sidoti & Company
Thomas Flaten - Lake Street Capital Markets
Operator
Good afternoon, and welcome to Assertio Holdings First Quarter 2024 Financial Results Call. [Operator Instructions] I would now like to turn the call over to Matt Kreps, Investor Relations for the company. Please go ahead.
Matthew Kreps
Thank you. Good afternoon, and thank you everyone for joining us today to discuss Assertio's first quarter 2024 financials. The news release covering our results for this period is now available on the Investor page of our website at investor.assertiotx.com. I would encourage you to review the release and the tables in conjunction with today's discussion.
With me today are Heather Mason, Interim CEO; Ajay Patel, CFO; and Paul Schwichtenberg, CCO. In just a moment, Heather will open the remarks and provide an overview of the business, then Ajay will cover our financial results and guidance, followed by Paul with an update on our commercial strategies. After that, we will take questions from our covering research analysts.
During this call, management will make projections and other forward-looking statements regarding our future performance. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those noted in this afternoon's press release as well as Assertio's filings with the SEC. These and other risks are more fully described in the risk factors section and other sections of our annual report on Form 10-K.
Our actual results may differ materially from those projected in the forward-looking statements. Assertio specifically disclaims any intent or obligation to update these forward-looking statements, except as required by law.
And with that, I will now turn the call over to Heather. Please go ahead.
Heather Mason
Thank you, Matt. Welcome everyone and thank you for joining us today. Since stepping into the interim CEO role in January, I am encouraged by the progress we are making at the business and I am deeply grateful to all of my colleagues at Assertio, who continually -- who continue to work tirelessly for our patients and clinicians and to drive long-term value for our shareholders.
We are off to a good start this year. Our first quarter is tracking with our full year guidance, calling for sales of $110 million to $125 million and EBITDA of $20 million to $30 million. There is demonstrated execution across several fronts. Rolvedon Q1 sales are up 32% quarter-over-quarter. This is Rolvedon's fifth consecutive quarter of demand growth, a critical success measure in the intensely competitive long-acting G-CSF category.